Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Jun 18;330(7505):1442-3.
doi: 10.1136/bmj.330.7505.1442.

Aspirin for everyone older than 50? Against

Colin Baigent  1
Affiliations
Review

Aspirin for everyone older than 50? Against

Colin Baigent. BMJ. .

Abstract

Current population screening for vascular disease is neither efficient nor effective. Peter Elwood and colleagues believe we should have a public information strategy highlighting the benefits (and risks) of aspirin for older people, but Colin Baigent argues that the evidence of benefit is not yet strong enough

PubMed Disclaimer

Figures

Figure 1
Figure 1
Who would benefit from daily aspirin? Credit: ERIC O'CONNELL/PHOTONICA
See this image and copyright information in PMC

Comment on

  • Aspirin for everyone older than 50? For.
    Elwood P, Morgan G, Brown G, Pickering J. Elwood P, et al. BMJ. 2005 Jun 18;330(7505):1440-1. doi: 10.1136/bmj.330.7505.1440. BMJ. 2005. PMID: 15961818 Free PMC article. Review.

References

    1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324: 71-86. - PMC - PubMed
    1. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321: 129-35. - PubMed
    1. Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K, et al. Randomised trial of prophylactic daily aspirin in British male doctors. BMJ 1988;296: 313-6. - PMC - PubMed
    1. Medical Research Council's General Practice Research Framework. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. Lancet 1998;351: 233-41. - PubMed
    1. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351: 1755-62. - PubMed